Share
Save
Hip Osteoarthritis and Foot Orthoses Trial (HOOT)
This trial is a randomized feasibility trial to determine the feasibility of comparing two different shoe inserts and on pain, quality of life and physical activity associated with hip osteoarthritis.
Study details:
Participants will be randomized to one of two groups - contoured prefabricated foot orthoses or flat shoe inserts (the comparator). Participants will be asked to use the inserts daily for a six week period. Adherence to the intervention will be monitored using a daily diary, as well as adverse events and co-interventions.
The primary outcome is feasibility domains (Demand, Implementation, Acceptability, Practicality) with secondary outcomes of change in hip-related pain and quality of life and physical activity levels. The primary time-point will be 6-weeks.
Eligibility criteria
Researchers look for people who fit a certain description, called eligibility criteria. See if you qualify.
Inclusion criteria
Exclusion criteria
Eligibility
Age eligible for study : 45 and older
Healthy volunteers accepted : No
Gender eligible for study: All
Things to know
Study dates
Study start: 2022-02-01
Primary completion: 2024-08-01
Study completion finish: 2025-10-26
Study type
TREATMENT
Phase
NA
Trial ID
NCT05138380
Intervention or treatment
DEVICE: Foot orthoses
DEVICE: Flat shoe insert
Conditions
- • Hip Osteoarthritis
Find a site
Closest Location:
La Trobe University
Research sites nearby
Select from list below to view details:
La Trobe University
Bundoora, Victoria, Australia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Participant Group/Arm | Intervention/Treatment |
---|---|
EXPERIMENTAL: Foot orthoses
| DEVICE: Foot orthoses
|
SHAM_COMPARATOR: Flat shoe insert
| DEVICE: Flat shoe insert
|
What is the study measuring?
Primary outcome
Primary Outcome Measure | Primary Outcome Description | Primary Outcome Time Frame |
---|---|---|
Feasibility: adherence | Recruitment rate (average 1 participant per week); 50% log-book completion rate (daily); drop-out \<20%; 35 hours per week adherence to intervention (log book) | 6 weeks |
Secondary outcome
Secondary Outcome Measure | Secondary Outcome Description | Secondary Outcome Time Frame |
---|---|---|
Hip-related pain | Hip osteoarthritis outcome score: pain sub-scale (HOOS-12). Scores range for 0 (better outcomes) - 100 (worse outcomes) | Baseline and 6 weeks |
Hip-related physical function | Hip osteoarthritis outcome score: function and daily living subscale. Scores range for 0 (better outcomes) - 100 (worse outcomes) | Baseline and 6 weeks |
Hip-related quality of life | hip osteoarthritis outcome score: quality of life subscale: Scores range for 0 (better outcomes) - 100 (worse outcomes) | Baseline and 6 weeks |
Fear of movement | Brief Fear of Movement Scale for osteoarthritis (BFOM); 0 to 24, with a higher score indicating lower fear of movement (better score) | Baseline and 6 weeks |
Depressive symptoms | Patient Health Questionnaire -9: Scored from 0 to 27, participants can be classified as having mild (≥ 5), moderate (≥ 10), moderately severe (≥ 15) and severe (≥ 20) depressive symptoms. | Baseline and 6 weeks |
Physical activity- Self-reported | The International Physical Activity Questionnaire: Participants will be asked to recall their physical activity over the last 7 days with regard to vigorous physical activity, moderate physical activity, walking and sitting. | Baseline and 6 weeks |
Physical activity- Walking based physical activity | Will be measured with a tri-axial accelerometer-based activity monitor that is attached on the thigh (activPAL model 4 micro; PAL Technologies Ltd, Glasgow, UK) and will be expressed as a) daily minutes of moderate and vigorous physical activity using the established 100 steps/minute threshold and b) total daily steps (which captures both inside and outside the home walking activity). | Baseline and 6 weeks |
Global rating of change- Physical activity | Seven point rating scale. Much better, better, a little better, no change, a little worse, worse, much worse | Week 6 |
Global rating of change- Symptoms | Seven point rating scale. Much better, better, a little better, no change, a little worse, worse, much worse | Week 6 |
Frequently Asked Questions
Please note: some questions and answers are submitted by anonymous patients or using AI, and have not been verified by Clinrol
No questions submitted. Be the first to ask a question!